Cargando…

Co-delivery of dihydroartemisinin and docetaxel in pH-sensitive nanoparticles for treating metastatic breast cancer via the NF-κB/MMP-2 signal pathway

Metastasis is a major barrier in cancer chemotherapy. Prolonged circulation and rapid, specific intracellular drug release are two main goals in the development of nanoscale drug delivery systems to treat metastatic breast cancer. In this study, we investigated the anti-metastasis effect of docetaxe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Jin, Tan, Zeng, Diao, Lu, Ji, Zhonghua, Zhu, Jiahuan, Chen, Wei, Hu, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2018
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080987/ https://www.ncbi.nlm.nih.gov/pubmed/35541720 http://dx.doi.org/10.1039/c8ra02833h

Ejemplares similares

Tumor-targeting, pH-sensitive nanoparticles for docetaxel delivery to drug-resistant cancer cells
por: Tran, Tuan Hiep, et al.
Publicado: (2015)

Dihydroartemisinin attenuates autoimmune thyroiditis by inhibiting the CXCR3/PI3K/AKT/NF-κB signaling pathway
por: Liu, Huijuan, et al.
Publicado: (2017)

Dihydroartemisinin inhibits catabolism in rat chondrocytes by activating autophagy via inhibition of the NF-κB pathway
por: Jiang, Li-Bo, et al.
Publicado: (2016)

pH-Sensitive Chitosan Nanoparticles for Salivary Protein Delivery
por: Zhu, Yi, et al.
Publicado: (2021)

Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies
por: Li, Qingrong, et al.
Publicado: (2021)

Dihydroartemisinin Attenuated Intervertebral Disc Degeneration via Inhibiting PI3K/AKT and NF-κB Signaling Pathways
por: Liao, Zhiheng, et al.
Publicado: (2022)

Glucose-Modified Zein Nanoparticles Enhance Oral Delivery of Docetaxel
por: Xing, Yabing, et al.
Publicado: (2022)

Dihydroartemisinin-Loaded Magnetic Nanoparticles for Enhanced Chemodynamic Therapy
por: Guo, Shengdi, et al.
Publicado: (2020)

Docetaxel Treatment for Metastatic Hormone-sensitive Prostate Cancer in Daily Practice
por: de Groot, Ietsen, et al.
Publicado: (2021)

Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice
por: Lendorf, Maria Elisabeth, et al.
Publicado: (2021)

Dihydroartemisinin attenuates lipopolysaccharide-induced acute lung injury in mice by suppressing NF-κB signaling in an Nrf2-dependent manner
por: Huang, Xiao-Ting, et al.
Publicado: (2019)

Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer
por: Chen, Yang, et al.
Publicado: (2022)

S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer
por: Diao, Feiyu, et al.
Publicado: (2019)

Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
por: Chen, Hongbo, et al.
Publicado: (2010)

NF-κB inhibition is associated with OPN/MMP-9 downregulation in cutaneous melanoma
por: Guarneri, Claudio, et al.
Publicado: (2017)

Inhibitory effect of midazolam on MMP-9, MMP-1 and MMP-13 expression in PMA-stimulated human chondrocytes via recovery of NF-κB signaling
por: Wang, Jen-Jui, et al.
Publicado: (2012)

Resistance to Dihydroartemisinin
por: Cojean, Sandrine, et al.
Publicado: (2006)

Resistance to Dihydroartemisinin
por: Legrand, Eric, et al.
Publicado: (2007)

Novel pH-sensitive nanoformulated docetaxel as a potential therapeutic strategy for the treatment of cholangiocarcinoma
por: Du, Nan, et al.
Publicado: (2015)

Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells
por: Wang, Qiuyan, et al.
Publicado: (2015)

Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF-κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis
por: Ding, Dong, et al.
Publicado: (2022)

Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer
por: Talwar, Harkirat Singh
Publicado: (2021)

Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer
por: Isaksson, Jenny, et al.
Publicado: (2021)

Outcomes of Older Men Receiving Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer
por: Lage, Daniel E., et al.
Publicado: (2021)

pH-sensitive degradable nanoparticles for highly efficient intracellular delivery of exogenous protein
por: Xu, Dan, et al.
Publicado: (2013)

Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB Pathways
por: Wu, Long, et al.
Publicado: (2019)

Preparation of pH Sensitive Pluronic-Docetaxel Conjugate Micelles to Balance the Stability and Controlled Release Issues
por: Liang, Yanchao, et al.
Publicado: (2015)

Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate
por: Ishibashi, Masaya, et al.
Publicado: (2012)

Self-assembled dihydroartemisinin nanoparticles as a platform for cervical cancer chemotherapy
por: Lu, Yun, et al.
Publicado: (2020)

Dihydroartemisinin-Loaded Chitosan Nanoparticles Inhibit the Rifampicin-Resistant Mycobacterium tuberculosis by Disrupting the Cell Wall
por: Gu, Xiujuan, et al.
Publicado: (2021)

Delivery of docetaxel using pH-sensitive liposomes based on D-α-tocopheryl poly(2-ethyl-2-oxazoline) succinate: Comparison with PEGylated liposomes
por: Han, Shu, et al.
Publicado: (2019)

Effect of low extracellular pH on NF-κB activation in macrophages()
por: Gerry, A.B., et al.
Publicado: (2014)

Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer
por: Zhang, Yumin, et al.
Publicado: (2016)

pH-Sensitive Chitosan–Heparin Nanoparticles for Effective Delivery of Genetic Drugs into Epithelial Cells
por: Pilipenko, Iuliia, et al.
Publicado: (2019)

pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia
por: Liu, Lin, et al.
Publicado: (2021)

Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis
por: Jiang, Jie, et al.
Publicado: (2016)

Dihydroartemisinin Protects against Dextran Sulfate Sodium-Induced Colitis in Mice through Inhibiting the PI3K/AKT and NF-κB Signaling Pathways
por: Li, Ning, et al.
Publicado: (2019)

Dihydroartemisinin ameliorates innate inflammatory response induced by Streptococcussuis-derived muramidase-released protein via inactivation of TLR4-dependent NF-κB signaling
por: Ji, Yun, et al.
Publicado: (2023)

A Comparison of Hepatocyte Cytotoxic Mechanisms for Docetaxel and PLGA-Docetaxel Nanoparticls
por: Daraei, Bahram, et al.
Publicado: (2017)

pH-Sensitive Biomaterials for Drug Delivery
por: Zhuo, Shijie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ggce10nhes16ljkkgt5rsa0pg5